@article{c38e9838b90a4982b1b8b7efb0106e88,
title = "US “Safety Net” Clinics Provide Access to Effective Contraception for Adolescents and Young Women, 2017–2019",
abstract = "Objectives. To describe patterns of providing moderately effective versus the most effective contraception and of providing implants versus intrauterine devices in US community health centers. Methods. We conducted a historical cohort study (2017–2019). Outcomes were woman-level receipt of most effective contraception (long-acting reversible contraception; implants and intrauterine devices) or moderately effective contraception. We used logistic regression to identify patient and clinic factors associated with providing (1) most versus moderately effective methods, and (2) implants versus intrauterine devices. We calculated adjusted probabilities for both outcomes by age group. Results. We included 199 652 events of providing contraception to 114 280 women in 410 community health centers. Adjusted probabilities were similar across age groups for moderately versus most effective methods. However, the adjusted marginal means for receiving an implant compared with an intrauterine device were highest for adolescents (15–17 years: 78.2% [95% confidence interval (CI) 5 75.6%, 80.6%]; 18–19 years: 69.5% [95% CI 5 66.7%, 72.3%]). Women{\textquoteright}s health specialists were more likely to provide most versus moderately effective contraception. Conclusions. Community health centers are an important access point for most effective contraception for women of all ages. Adolescents are more likely to use implants than intrauterine devices.",
author = "Darney, {Blair G.} and Biel, {Frances M.} and Jee Oakley and Rodriguez, {Maria I.} and Cottrell, {Erika K.}",
note = "Funding Information: B. G. Darney{\textquoteright}s institution receives research support from Merck/Organon, and B. G. Darney serves on the Society of Family Planning board of directors. M. I. Rodriguez has served as a contraceptive trainer for Merck and the American Congress of Obstetricians and Gynecologists. She has served on a Bayer advisory board. She has served as a consultant for the World Health Organization. Her institution has received research funding from the Laura and John Arnold Foundation, the National Institutes of Health, Merck, and the Robert Wood Johnson Foundation on projects on which she is the PI. OHSU has reviewed and managed M. I. Rodriguez{\textquoteright}s potential conflicts of interest. Funding Information: Merck/Organon supported this study (investigator initiated grant IIS# 60206; B. G. D., principal investigator [PI]), and the Office of Population Affairs (grant 1 FPRPA006071-01-00; B. G. D., PI), and the Agency for Healthcare Research and Quality (grant 1R01HS025155-01; E. K. C., PI) provided partial support. Funding Information: Merck/Organon supported this study (investigator initiated grant IIS# 60206; B. G. D., principal investigator [PI]), and the Office of Population Affairs (grant 1 FPRPA006071-01-00; B. G. D., PI), and the Agency for Healthcare Research and Quality (grant 1R01HS025155-01; E. K. C., PI) provided partial support. This work was conducted with the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) Clinical Research Network (CRN). ADVANCE is a CRN in the National Patient-Centered Outcomes Research Network (PCORnet). ADVANCE is led by Oregon Community Health Information Network, Inc. in partnership with Health Choice Network, Fenway Health, Oregon Health & Science University (OHSU), and the Robert Graham Center HealthLandscape. ADVANCE{\textquoteright}s participation in PCORnet is funded by the Patient-Centered Outcomes Research Institute (contract RI-OCHIN-01-MC). Funding Information: This work was conducted with the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) Clinical Research Network (CRN). ADVANCE is a CRN in the National Patient-Centered Outcomes Research Network (PCORnet). ADVANCE is led by Oregon Community Health Information Network, Inc. in partnership with Health Choice Network, Fenway Health, Oregon Health & Science University (OHSU), and the Robert Graham Center HealthLandscape. ADVANCE{\textquoteright}s participation in PCORnet is funded by the Patient-Centered Outcomes Research Institute (contract RI-OCHIN-01-MC). Publisher Copyright: {\textcopyright} 2022 American Public Health Association Inc.. All rights reserved.",
year = "2022",
month = jun,
doi = "10.2105/AJPH.2022.306913",
language = "English (US)",
volume = "112",
pages = "S555--S562",
journal = "American journal of public health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
}